United States · Series B startup
2 rounds we have observed, with the 18 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised this month
Funding summaryUpdated 26 Oct 2026
$335Mraised across 2 rounds since 2025, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Juvia GroupLead
Bessemer Venture Partners
Polaris Partners
Temasek Holdings
ARCH Venture Partners
Breyer Capital
Safar Partners
Vida Ventures
Leaps by Bayer
Balyasny Asset Management L.p.
BB BiotechReported by Google News search
Source recorded
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Soufflé Therapeutics's investors include Bessemer Venture Partners, Polaris Partners, Temasek Holdings, ARCH Venture Partners and Juvia Group, and 13 more on record. Juvia Group led its latest round.
Soufflé Therapeutics has raised $335M across 2 rounds since 2025.
Soufflé Therapeutics's most recent round was a Series B of $135M in Oct 2026, led by Juvia Group.
Soufflé Therapeutics's largest round on record is $200M (Series A), in Jan 2025.
Soufflé Therapeutics's first round on record, in Jan 2025, was backed by Bessemer Venture Partners, Polaris Partners and Temasek Holdings and 2 others.
Soufflé Therapeutics's latest named round is a Series B, in Oct 2026.
Soufflé Therapeutics is based in the United States.
Juvia Group led the Series B in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
